Dewi Guellec

Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial

Jordi Díaz‐Manera, Priya S. Kishnani, Hani Kushlaf et al. · The Lancet Neurology · 2021 · 184 citations · Full text

Veterinary Medicine, Internal Medicine, Pharmacotherapy +3

Epidemiology of neurological manifestations in Sjögren's syndrome: data from the French ASSESS Cohort

Guillermo Carvajal Alegria, Dewi Guellec, Xavier Mariette et al. · RMD Open · 2016 · 119 citations · Full text

Medicine, Neurology, Neuroimmunology +14

Effect of Tocilizumab on Disease Activity in Patients With Active Polymyalgia Rheumatica Receiving Glucocorticoid Therapy

Valérie Devauchelle‐Pensec, Guillermo Carvajal Alegria, Emmanuelle Dernis et al. · JAMA · 2022 · 118 citations · Full text

Pharmacy, Pharmacotherapy, Hypersensitivity +16

Comparison of 2002 AECG and 2016 ACR/EULAR classification criteria and added value of salivary gland ultrasonography in a patient cohort with suspected primary Sjögren’s syndrome

M Le Goff, Divi Cornec, Sandrine Jousse‐Joulin et al. · Arthritis Research & Therapy · 2017 · 109 citations · Full text

Medicine, Internal Medicine, Autoimmunity +16

Neurological manifestations of COVID-19 in adults and children

Sung‐Min Cho, Nicole White, Lavienraj Premraj et al. · Brain · 2022 · 84 citations · Full text

Medicine, Infectious Diseases, Pediatrics +8